Tag: Oncology

Genotype-Specific Microparticle Treatment for Brain Cancer

Researchers from Harvard and MIT have developed microparticles that can treat a specific genetic subtype of glioma, a brain cancer. The microparticles slowly release a drug that specifically targets cancer cells that rely on a particular enzyme. During surgery to remove the brain tumor, clinicians can conduct a rapid (30 min) genetic test on a [&he (Read more...)

New Device for Testing Immunotherapies on Tumor Fragments

Immuno-oncology, a rapidly developing field that harnesses the body’s immune system to attack cancers, lacks effective methods of testing potential therapies. In addition to animal studies, tiny bits of tumors are placed, along with chemical compounds being tested, within multiwell plates and watched over using a number of techniques. While t (Read more...)

Molecular Sensor to Detect if Cancer Drug is Working

Being able to monitor the chemical content of cancer cells may help scientists develop new anti-cancer medications. Additionally, it may also lead to personalized drug therapies for cancer patients that all too often end up trying multiple medications before finding one that works. Chemists at MIT have come up with just such a tool for […]

Method Tracks How Cancer Drugs Spread to Tumor Cells

When it comes to anti-cancer drugs, it’s not only their effectiveness at killing the intended target that we want to know, but also their ability to reach and penetrate the cancer cells. Knowing whether the drug actually enters cancer cells can be as important as whether it’s effective once inside. Now researchers at Francis Crick (Read more...)

Embolx Announces FDA Clearance for Next Generation Sniper Balloon Occlusion Microcatheter

Embolx, a new medical device company out of Silicon Valley, develops microcatheters for arterial endoembolization procedures, and now their next-generation Sniper Balloon Occlusion Microcatheter will be available in the US. The new family of microcatheters shows significant improvement over previous devices, and offers physicians enhanced performan (Read more...)

Hairy Frosted Glass Slides Capture Circulating Tumor Cells for Screening and Early Diagnosis

Biopsies are typically the way prostate cancer is identified, but prostate cancers also release circulating tumor cells (CTCs) that are telltale signs of the presence of the disease. Because they’re so rare and difficult to separate from whole blood, CTCs remain rarely used for establishing diagnoses. Researchers from the Chinese Academy of S (Read more...)

Advanced Cancer Diagnostics Reduce Frequency of Misdiagnoses: Interview with Precipio CEO Ilan Danieli

According to 2010-2012 data from the National Cancer Institute (NCI), 40% of men and women will be diagnosed with cancer in their lifetime. In all its forms, cancer is known to be a clinically and emotionally challenging disease to manage. Despite the fact that each year 455 men and women per 100,000 patients are diagnosed […]